MedPath

Cardiovascular Health Effects of Flavanol Rich Chocolate

Not Applicable
Completed
Conditions
Endothelial Dysfunction
Registration Number
NCT01308892
Lead Sponsor
Wageningen University
Brief Summary

In the CHOC study the investigators will examine the effect of chocolate flavanols on vascular function, inflammation, oxidative stress and markers of endothelial function. The effects of both acute consumption and prolonged consumption will be studied. The secondary objectives are to investigate if daily intake of chocolate flavanols for 4 weeks will improve the response to a high fat/high energy challenge.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Male
Target Recruitment
44
Inclusion Criteria
  • Male
  • 45-70 years old
  • BMI between 25 and 32 kg/m2
Exclusion Criteria
  • Urine glucose concentrations outside normal ranges (> 0,25 g/l)
  • Fasting blood glucose < 7.0 mmol/L)
  • Systolic Bp > 160 mmHg or diastolic Bp > 100 mmHg
  • Blood Hb values below 8.4 mmol/L
  • Allergic to cow milk, dairy products or chocolate
  • Vegetarian
  • Tobacco smoker
  • Diagnosed with any long-term medical condition (e.g., diabetes, hemophilia, cardiovascular disease, anemia, gastrointestinal disease, renal failure)

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Primary Outcome Measures
NameTimeMethod
Blood pressure0, 4wk
FMD0, 4wk
PWA0, 4wk
Secondary Outcome Measures
NameTimeMethod
leukocyte count and activation0, 4wk
PBMC gene expression0 and 2 hrs

acute study part

Markers of inflammation and ED0, 4wk
Blood pressure0 and 2h

acute study part

FMD0 and 2hrs

acute study part

PWA0 and 2 hrs

acute study part

Leukocyte count and activation0 and 2 hrs

acute study part

markers of inflammation and ED0 and 2hrs

acute study part

Trial Locations

Locations (1)

Wageningen universiteit division of human

🇳🇱

Wageningen, Gelderland, Netherlands

Wageningen universiteit division of human
🇳🇱Wageningen, Gelderland, Netherlands

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.